Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Linda van Bijsterveldt

BSc, MRes

I am looking into the role of a particular miRNA in regulating breast cancer pathogenesis. We have shown that over-expression of this miRNA alters the cell cycle profile of triple-negative breast cancer cell lines and are looking to target this with checkpoint kinase inhibitors, based on a concept called synthetic lethality.

graduated from Leiden University (2016) with a BSc in Bio-Pharmaceutical Sciences. I then obtained a MSc by Research in Oncology (2017) from the University of Oxford (Chromosome Integrity Group), where I identified suppressors of the synthetic lethality resulting from loss of SETD2 and WEE1.